[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 505
Citations 0
Comment & Response
June 2014

Was Risk of Suicide Underestimated?

Author Affiliations
  • 1Mental Health Center Copenhagen, University of Copenhagen, Copenhagen, Denmark
  • 2National Center for Register-Based Research, University of Aarhus, Aarhus, Denmark
JAMA Psychiatry. 2014;71(6):716. doi:10.1001/jamapsychiatry.2014.148

To the Editor We carefully read the article by Khan and colleagues.1 The authors evaluated the mortality risk and risk of suicide among adult patients with a diagnosis of schizophrenia, depression, bipolar disorder, anxiety disorders, or attention-deficit/hyperactivity disorder participating in clinical trials conducted by pharmaceutical companies. The trials were reported to the US Food and Drug Administration for approval to market pharmaceutical agents and to evaluate whether psychopharmacological agents worsen this risk.

First Page Preview View Large
First page PDF preview
First page PDF preview